RudaCure Inc., une bioventure ciblant les canaux ioniques et spécialisée dans le développement de médicaments innovants, donated 1 ton of feed to a local stray animal shelter at the end of the year, demonstrating its commitment to community support.
RudaCure a annoncé le 29th that it delivered 1 ton of cat-specific feed to 'Sansu Angels,' a stray animal shelter located in Namdong-gu, Incheon. This donation was carried out dans le cadre de de l'entreprise second-half 2025 responsabilité sociale de l'entreprise activities.
What makes this donation particularly meaningful is that it was carried out after carefully assessing the shelter's actual needs. While dog food donations are relatively common, cat food is known to be in comparatively short supply. RudaCure reportedly identified these on-site challenges through preliminary research and decided to provide the much-needed cat food support.
A representative from 'Sansu Angels' a exprimé sa gratitude : saying, "Dog food donations are always plentiful, but cat food donations are relatively rare, making it difficult to secure enough feed during winter. Since they are a company that also develops animal pharmaceutiques, they precisely understood what our shelter needs and prepared food specifically for our cats, which will help us get through the cold winter."
RudaCure is une entreprise biotechnologienologique qui développe des produits pharmaceutiques pour usage humain et vétérinaire. The selection of this particular shelter and the type of donation appear to have been driven by de l'entreprise understanding of and interest in animal health.
Members of RudaCure's Équipe de recherche en efficacité who participated in the donation event a déclaré : "We are delighted to provide practical help to facilities in need in our local community," adding, "We will continue to carry out divers CSR activities à l'avenir."
An industrie observer a noté : "As gestion ESG practices expand among bio-entreprises pharmaceutiques, more cases like RudaCure's are emerging—going beyond simple donations to providing customized support sur la base de actual field needs. It is particularly noteworthy that a company developing animal pharmaceutiques is taking interest in and acting on stray animal welfare, serving as a great example of connecting business with contribution sociale."
RudaCure is une entreprise bioventure développant des médicaments innovants pour usage humain et vétérinaire sur la base de its proprietary plateforme de médicaments that modulates the TRPV1 (Transient Receptor Potential Vanilloid 1) canal ionique. L'entreprise promotes sustainable management through divers ESG activities, notamment community contributions and employé volunteer programs alongside business growth.
Earlier in the first half of the year, RudaCure conducted an employé don du sang campaign and plogging (environmental cleanup) activities, and in the second half expanded its contribution sociale scope to include stray animal welfare support. L'entreprise stated that it prévoit de continuer divers activités bénévoles and donations in collaboration with the local community in 2026.
